A Study to Evaluate the Analgesic Properties of Topically Applied Menthol in Marathon Participants
Public ClinicalTrials.gov record NCT07873242. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Real-World Evidence Study to Evaluate the Analgesic Properties of Topically Applied Menthol and Its Impact on Quality of Life in Marathon Participants
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of the research study is to better understand the factors that impact pain experience in adult (18+ years) marathon runners participating in the 2026 Chicago Marathon and to better understand if topically applied menthol provides effective pain relief and impacts quality-of-life outcomes when used during the marathon, in the Recovery Zone immediately after the marathon, or during post-race recovery. The main questions the study aims to answer are: * Does topically applied menthol (gel and roll-on formats) reduce pain when applied in the Recovery Zone immediately after a marathon? * What are the sensory attributes (e.g., cooling sensation) of topically applied menthol (gel and roll-on) when used in the Recovery Zone immediately after a marathon? * How do participants assess the effects of topically applied menthol products used during and/or after a marathon on pain relief, performance, recovery, and sleep-related quality-of-life outcomes? Researchers will evaluate participant-reported pre- and post-application pain scores in the Recovery Zone immediately following the marathon and post-race outcomes to assess analgesic effectiveness, sensory attributes, and quality-of-life outcomes associated with Biofreeze use. Participants will: * Provide documented informed consent prior to participation. * Self-select to use Biofreeze products during and/or after the race. * Complete one or both of the following: 1. End of Race Questionnaire (includes pain score before and after Biofreeze application, sensory assessments, and demographics). 2. Post-Race Questionnaire (includes retrospective recall of pain relief, product use, sensory experience, sleep-related outcomes and demographic data).
Study identification
- NCT ID
- NCT07873242
- Recruitment status
- Not yet recruiting
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 600 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 11, 2026 (Estimated)
- Primary completion
- Oct 13, 2026 (Estimated)
- Completion
- Oct 13, 2026 (Estimated)
- Last update posted
- Oct 16, 2026
2026
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Curion Insights LLC | Deerfield | Illinois | 60015 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07873242, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 16, 2026 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT07873242 live on ClinicalTrials.gov.